Abiopharma

🔍 LAUREN RALPH (Director)

Company: RALPH LAUREN CORP (RL)

Report Date: 2026-04-10

Detailed Transactions and Holdings:

• Acquired 1,260 shares of Class A Common Stock (Direct)
  Date: 2026-04-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 788,594.18 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-10 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 35,854.00 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units of the Issuer's Class A Common Stock payable as a result of the payment of a cash dividend on the Issuer's Class A Common Stock. The restricted stock units are payable solely in shares of the Issuer's Class A Common Stock issued to the Reporting Person in respect of restricted stock units previously granted under the Issuer's 1997 Stock Incentive Plan.
• F2: These shares of Class A Common Stock are held by a revocable trust of which the reporting person is sole trustee and sole beneficiary.